[HTML][HTML] The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients

AM Martelli, C Evangelisti, F Chiarini, JA McCubrey - Oncotarget, 2010 - ncbi.nlm.nih.gov
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) signaling axis plays a central role in cell proliferation, growth, and survival under …

The bone marrow microenvironment and leukemia: biology and therapeutic targeting

EAR Sison, P Brown - Expert review of hematology, 2011 - Taylor & Francis
Multiple studies have demonstrated that interaction with the bone marrow stromal
microenvironment contributes to the survival of leukemia cells. One explanation for this …

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML

Z Zeng, Y Xi Shi, IJ Samudio, RY Wang… - Blood, The Journal …, 2009 - ashpublications.org
Abstract SDF-1α/CXCR4 signaling plays a key role in leukemia/bone marrow
microenvironment interactions. We previously reported that bone marrow–derived stromal …

CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia

Y Chen, R Jacamo, M Konopleva… - The Journal of …, 2013 - Am Soc Clin Investig
We examined the role of microRNAs (miRNAs) in targeting the stromal-derived factor
1α/CXCR4 (SDF-1α/CXCR4) axis to overcome chemoresistance of AML cells. Microarray …

The good and the bad of chemokines/chemokine receptors in melanoma

A Richmond, J Yang, Y Su - Pigment cell & melanoma research, 2009 - Wiley Online Library
Chemokine ligand/receptor interactions affect melanoma cell growth, stimulate or inhibit
angiogenesis, recruit leukocytes, promote metastasis, and alter the gene expression profile …

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

AM Martelli, C Evangelisti, F Chiarini… - Expert opinion on …, 2009 - Taylor & Francis
Background: The PI3K/Akt/mammalian target of rapamycin (mTOR) signaling pathway plays
a central role in cell growth, proliferation and survival not only under physiological …

[HTML][HTML] CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth

K Beider, M Begin, M Abraham, H Wald, ID Weiss… - Experimental …, 2011 - Elsevier
OBJECTIVE: The chemokine receptor CXCR4 and its ligand CXCL12 are involved in the
progression and dissemination of a diverse number of solid and hematological …

Role of CXCR4 in the progression and therapy of acute leukaemia

L Su, Z Hu, YG Yang - Cell proliferation, 2021 - Wiley Online Library
CXCR4 is expressed on leukaemia cells and haematopoietic stem cells (HSCs), and its
ligand stromal‐derived factor 1 (SDF‐1) is produced abundantly by stromal cells in the bone …

The emerging role of suppressors of cytokine signaling (SOCS) in the development and progression of leukemia

E Keewan, K Matlawska-Wasowska - Cancers, 2021 - mdpi.com
Simple Summary The suppressors of cytokine signaling (SOCS) are known cytokine-
inducible negative regulators of JAK/STAT and other cell signaling pathways. Deregulation …

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia

E Tavernier-Tardy, J Cornillon, L Campos, P Flandrin… - Leukemia research, 2009 - Elsevier
We analysed, by flow cytometry, the “adhesive” phenotype of acute myelogenous leukemia
(AML) cells from 36 patients treated in our institution. In univariate analysis, the main …